These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23072062)

  • 21. Update in paroxysmal nocturnal hemoglobinuria.
    Hillmen P
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):391-3. PubMed ID: 22895241
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of eculizumab to correct paroxysmal cold hemoglobinuria.
    Gregory GP; Opat S; Quach H; Shortt J; Tran H
    Ann Hematol; 2011 Aug; 90(8):989-90. PubMed ID: 21110191
    [No Abstract]   [Full Text] [Related]  

  • 23. A new era of hope for the world's most neglected diseases.
    The
    PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria.
    Berzuini A; Montanelli F; Prati D
    N Engl J Med; 2010 Sep; 363(10):993-4. PubMed ID: 20818912
    [No Abstract]   [Full Text] [Related]  

  • 25. Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab.
    Danilov AV; Smith H; Craigo S; Feeney DM; Relias V; Miller KB
    Leuk Res; 2009 Jun; 33(6):e4-5. PubMed ID: 18952283
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab.
    van Bijnen ST; Vermeer H; Mourisse JM; de Witte T; van Swieten HA; Muus P
    Eur J Haematol; 2011 Oct; 87(4):376-8. PubMed ID: 21623921
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pathophysiology and treatment of paroxysmal nocturnal hemoglobinuria (PNH)--recent advances].
    Shichishima A; Shichishima T;
    Rinsho Ketsueki; 2009 Dec; 50(12):1679-86. PubMed ID: 20068274
    [No Abstract]   [Full Text] [Related]  

  • 28. Eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
    Hill A
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):849-50. PubMed ID: 16491626
    [No Abstract]   [Full Text] [Related]  

  • 29. [Medicoeconomic data on rare disease drugs: a move towards more transparency?].
    Schwebig A; Duguet C; Ferry A; Bougé C; Fagon JY; Bismuth C; Ramon J
    Presse Med; 2012 May; 41 Suppl 1():S57-64. PubMed ID: 22487716
    [No Abstract]   [Full Text] [Related]  

  • 30. Genzyme deal set to alter biotech landscape.
    Ledford H
    Nature; 2011 Feb; 470(7335):449. PubMed ID: 21350458
    [No Abstract]   [Full Text] [Related]  

  • 31. [Novel therapeutics for paroxysmal nocturnal hemoglobinuria].
    Nishimura J
    Rinsho Ketsueki; 2011 Oct; 52(10):1515-24. PubMed ID: 21971228
    [No Abstract]   [Full Text] [Related]  

  • 32. Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria.
    Tomita A; Shirasugi Y; Ito T; Tsurumi H; Naoe T
    Ann Hematol; 2012 Jul; 91(7):1139-41. PubMed ID: 22080148
    [No Abstract]   [Full Text] [Related]  

  • 33. Eculizumab.
    Parker CJ; Kar S; Kirkpatrick P
    Nat Rev Drug Discov; 2007 Jul; 6(7):515-6. PubMed ID: 17715500
    [No Abstract]   [Full Text] [Related]  

  • 34. Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria.
    Knoll BM; Letendre L; Steensma DP
    Am J Hematol; 2008 Nov; 83(11):881-3. PubMed ID: 18756538
    [No Abstract]   [Full Text] [Related]  

  • 35. Big pharma moves from 'blockbusters' to 'niche busters'.
    Dolgin E
    Nat Med; 2010 Aug; 16(8):837. PubMed ID: 20689537
    [No Abstract]   [Full Text] [Related]  

  • 36. Paroxysmal nocturnal hemoglobinuria--hemolysis before and after eculizumab.
    Risitano AM; Notaro R; Luzzatto L; Hill A; Kelly R; Hillmen P
    N Engl J Med; 2010 Dec; 363(23):2270-2. PubMed ID: 21121856
    [No Abstract]   [Full Text] [Related]  

  • 37. Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure.
    Kelly RJ; Hill A; Arnold LM; Khursigara G; Kanagasundaram NS; Hillmen P
    Leuk Res; 2011 Apr; 35(4):560-2. PubMed ID: 21145109
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria.
    Emadi A; Brodsky RA
    Am J Hematol; 2009 Oct; 84(10):699-701. PubMed ID: 19705437
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
    Danilov AV; Brodsky RA; Craigo S; Smith H; Miller KB
    Leuk Res; 2010 May; 34(5):566-71. PubMed ID: 19954846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma in a patient in treatment with eculizumab.
    Manganoni AM; Pavoni L; Facchetti F; Farisoglio C; Sereni E; Calzavara-Pinton P
    Ann Hematol; 2012 Jan; 91(1):135-6. PubMed ID: 21465187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.